You are wrong on several counts. Revenues from Petrozene were reported in the latest Q. Petrozene is being tested by a large oil company as reported in a PR. That same company is buying Petrozene for testing, not being given free Petrozene.
My prediction of $1 by the end of 2015 was wrong. Freestone will get there, just not as soon as I had expected.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.